Literature DB >> 8710745

Iontophoresis of bases, nucleosides, and nucleotides.

R van der Geest1, F Hueber, F C Szoka, R H Guy.   

Abstract

PURPOSE: To investigate whether transdermal iontophoresis may be potentially useful for delivery of oligonucleotide drugs, the electrotransport of representative bases (uracil and adenine), nucleosides (uridine and adenosine) and nucleotides (AMP, ATP, GTP and imido-GTP) across mammalian skin in vitro has been considered.
METHODS: While the passive permeability of all compounds investigated (from 1 mM solutions at pH 7.4) was very low, the application of constant current iontophoresis (0.55 mA/cm2) significantly enhanced the transport of both charged and uncharged species.
RESULTS: The efficiency of delivery depended only weakly upon lipophilicity, varied quite linearly with concentration (for AMP and ATP), was inversely sensitive to molecular weight, and was strongly influenced by charge. Neutral solutes were delivered better from the anode than the cathode, as expected; post-iontophoresis, passive permeabilities were greater than those of the untreated controls, suggesting that iontophoretically-induced changes in barrier function cannot be completely repaired in in vitro model systems. The triphosphate nucleotides, ATP and GTP, were essentially completely metabolized (presumably to their corresponding mono-phosphates) during their iontophoretic delivery, while imido-GTP was apparently resistant to enzymatic attack; however, comparison of the transport data from AMP and ATP suggested that ATP metabolism occurred primarily after the rate-limiting step of iontophoresis.
CONCLUSIONS: The results obtained are consistent with the general patterns of behavior previously observed in investigations of amino acid and peptide electrotransport. It remains to be seen whether extension of the research described here to larger oligonucleotide species is a feasible long-term objective.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8710745     DOI: 10.1023/a:1016041904037

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  8 in total

1.  Iontophoretic delivery of amino acids and amino acid derivatives across the skin in vitro.

Authors:  P G Green; R S Hinz; C Cullander; G Yamane; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

2.  Effects of luciferin concentration on the quantitative assay of ATP using crude luciferase preparations.

Authors:  D M Karl; O Holm-Hansen
Journal:  Anal Biochem       Date:  1976-09       Impact factor: 3.365

3.  Adenylyl imidodiphosphate, an adenosine triphosphate analog containing a P--N--P linkage.

Authors:  R G Yount; D Babcock; W Ballantyne; D Ojala
Journal:  Biochemistry       Date:  1971-06-22       Impact factor: 3.162

4.  Transdermal transport of DNA antisense oligonucleotides by electroporation.

Authors:  T E Zewert; U F Pliquett; R Langer; J C Weaver
Journal:  Biochem Biophys Res Commun       Date:  1995-07-17       Impact factor: 3.575

Review 5.  The role of electroosmotic flow in transdermal iontophoresis.

Authors:  M J Pikal
Journal:  Adv Drug Deliv Rev       Date:  2001-03-01       Impact factor: 15.470

6.  Iontophoretic delivery of a series of tripeptides across the skin in vitro.

Authors:  P G Green; R S Hinz; A Kim; F C Szoka; R H Guy
Journal:  Pharm Res       Date:  1991-09       Impact factor: 4.200

Review 7.  Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

Authors:  C A Stein; Y C Cheng
Journal:  Science       Date:  1993-08-20       Impact factor: 47.728

8.  Iontophoretic delivery of oligonucleotides across full thickness hairless mouse skin.

Authors:  K R Oldenburg; K T Vo; G A Smith; H E Selick
Journal:  J Pharm Sci       Date:  1995-08       Impact factor: 3.534

  8 in total
  2 in total

1.  Transdermal delivery of antisense oligonucleotides with microprojection patch (Macroflux) technology.

Authors:  W Lin; M Cormier; A Samiee; A Griffin; B Johnson; C L Teng; G E Hardee; P E Daddona
Journal:  Pharm Res       Date:  2001-12       Impact factor: 4.200

Review 2.  Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.

Authors:  Ahlam Zaid Alkilani; Maelíosa T C McCrudden; Ryan F Donnelly
Journal:  Pharmaceutics       Date:  2015-10-22       Impact factor: 6.321

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.